Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.
Saved in:
| Title: | Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease. |
|---|---|
| Authors: | Pillai, Jagan A.1,2,3,4 (AUTHOR) pillaij@ccf.org, Bena, James5 (AUTHOR), Bekris, Lynn4,6 (AUTHOR), Kodur, Nandan4 (AUTHOR), Kasumov, Takhar7 (AUTHOR), Leverenz, James B.1,2,3,4 (AUTHOR), Kashyap, Sangeeta R.4,8 (AUTHOR) |
| Source: | Alzheimer's Research & Therapy. 3/16/2023, Vol. 15 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17589193 |
|---|---|
| DOI: | 10.1186/s13195-023-01203-y |